AGF39 Forte - Mesotherapy for Hair Loss, Cytokines, Growth Factor
Dimension(cm)
15.5(W) x 12.5(L) x 4.5(H)
Quantity & Composition
1 Box |
100mg x Forte 10 vials |
Forte 1 vial |
Cytokine 102.5㎍ |
Symptom
Male pattern, female pattern androgenetic alopecia & Thinning hair
Efficacy
Normalize the cytokine balance of the scalp tissue, thereby alleviating hair loss symptoms and promoting hair growth.
Main ingredient
· 7 Key growth factor cytokines: IGF-1, KGF, VEGF, bFGF, FGF9, Noggin, and SOD
· 21 amino acids, 10 vitamins, Zn, Mg, Coenzyme, ATP
· AHK-cu: Normalize hair growth cycle
· Glutatione: Reducing agent
Key Features
· Recombinant cytokines not derived from human tissue.
· Sterilized, Lyophilized, Vacuum packed ampules maintains high activity and purity.
· Used by 7 University medical centers & 800 domestic and foreign clinics.
· More than 3,000,000 procedures have performed.
SCI Journal Publication & Presentation
· Journal of Dermatology 2012: 39: 1-2
· World Congress for Hair Research 2013, Edinburgh – P056
· World Congress for Hair Research 2014, Jeju – P18
How to use
· Followed by a specialist's prescription at a hair clinic
Cautions
1. In case of having side effect such as red rash, swollenness and/or itching while using this cosmetic, or in case such symptoms appear by direct sunlight after using it, consult a dermatologist immediately.
2. Do not apply it on the part where tou have a scar, eczema or dernatits.
3. Precautions for treatment and storage.
1) Keep it out of the reach of children.
2) Avoid areas where direct sunlight hits.
Company Overview
AesMed Co., Ltd. is a cosmetics and medical device manufacturer and sales company specializing in hair loss treatment. For the past 22 years, we have been at the forefront of the domestic and international hair loss markets. We provide products to 7 university hospitals, 500 hospitals, clinics, and major hair transplant centers, and so far, 3 million procedures have been performed with Aesmed’s AGF39. The cytokine therapy for alopecia with AGF39 is now recognized as the standard mesotherapy solution for alopecia treatment.
In addition, the research results were introduced and published in the SCI Journal and the World Congress for Hair Research. (SCI Journal, Journal of Dermatology 2012:39:1-2 / World Congress for hair research 2013, Edinburgh, Scotland p056. / World Congress for Hair Research 2014, Jeju, Korea p180.) AGF39 is getting widely noted to the world by academic exchanges in the medical alopecia field as an essential method for treatment.
Other Products